You are here

Gilead's remdesivir endorsed as first Covid-19 treatment in Europe

ym-remdesivir--250620.jpg
The European healthcare regulator has recommended the conditional approval of Gilead Sciences' antiviral treatment, remdesivir, for use in Covid-19 patients, making it the first treatment to be on track to be green-lit in the continent.

[BRUSSELS] The European healthcare regulator has recommended the conditional approval of Gilead Sciences' antiviral treatment, remdesivir, for use in Covid-19 patients, making it the first treatment to be on track to be green-lit in the continent.

The European Medicines Agency (EMA) said...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes